Kevin Sidow Joins Ceterix Orthopaedics Board of Directors as Chairman
MENLO PARK, California – November 2011 – Medical device company, Ceterix® Orthopaedics, Inc., developer of novel surgical tools for arthroscopic procedures, today announced that Kevin Sidow has joined the company’s Board of Directors as Chairman.
Mr. Sidow, President and CEO of Moximed, Inc., has over twenty years of orthopaedic medical device experience. Prior to his current role he was President and CEO of St. Francis Medical Technologies, Inc., a privately held company that developed innovative treatments for patients suffering from degenerative spinal disorders. SFMT was sold in January 2007 to Kyphon, Inc., for $725 million. Prior to joining SFMT, Kevin was the Worldwide President of DePuy, Inc., where he oversaw the global orthopaedic, spine, trauma, and sports medicine businesses.
“Kevin brings relevant experience and a track record of success in corporate and start-up businesses to our Board of Directors,” said John McCutcheon, Ceterix president and CEO. “We are very excited to have him as part of our team.”
Mr. Sidow will serve on the Ceterix Board of Directors along with Mark Colella, Josh Makower, M.D., John McCutcheon, Justin Saliman, M.D., and Charles Warden.
About Ceterix Orthopaedics
Ceterix Orthopaedics, Inc. develops novel surgical tools for arthroscopic procedures. The technology enables surgeons to place stitches in very tight joint compartments, while protecting sensitive surrounding structures such as nerves, arteries and cartilage. This technology has applications in numerous procedures in knees, hips, and shoulders.
Ceterix was founded in October 2010 based on the inventions of Dr. Justin Saliman, who envisioned improving the outcomes of arthroscopic procedures by enabling surgeons to place suture patterns that can only be done in open procedures, or not at all, today. The company is based in Menlo Park, California.